Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Anti-CD33 antibodies, anti-CD33/anti-CD3 bispecific antibodies and uses thereof

Anti-CD33 antibodies, anti-CD33/anti-CD3 bispecific antibodies and uses thereof

US Patent 11466082 · Granted Oct 11, 2022

Estimated economic value: $358,234,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

EGFR and C-met fibronectin type III domain binding molecules2025
CD137 binding fibronectin type III domains2025
GPRC5D chimeric antigen receptors and cells expressing the same2024
Methods of treating cancers and enhancing efficacy of T cell redirecting therape2024
Prostate specific membrane antigen binding fibronectin type iii domains2024
Methods of treating cancers and enhancing efficacy of T cell redirecting therape2024
Anti-GPRC5D antibodies, bispecific antigen binding molecules that bind GPRC5D an2024
Serum albumin-binding fibronectin type III domains2023
Materials and methods for improved single chain variable fragments2023
Anti-GPRC5D antibodies, bispecific antigen binding molecules that bind GPRC5D an2023
Anti-CD3 antibodies and uses thereof2023
Anti-CD3 antibodies and uses thereof2023